SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601485-24-000037
Filing Date
2024-05-24
Accepted
2024-05-23 17:41:48
Documents
18
Period of Report
2024-05-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K angn-20240523.htm   iXBRL 8-K 22996
2 EX-99.1 a2024-05x23xxeltxxxph1am.htm EX-99.1 14225
6 a2024-05x23xxeltxxxph1am001.jpg GRAPHIC 295455
7 a2024-05x23xxeltxxxph1am002.jpg GRAPHIC 260097
8 a2024-05x23xxeltxxxph1am003.jpg GRAPHIC 327107
9 a2024-05x23xxeltxxxph1am004.jpg GRAPHIC 131656
  Complete submission text file 0001601485-24-000037.txt   1569816

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20240523.xsd EX-101.SCH 1989
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20240523_lab.xml EX-101.LAB 22786
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20240523_pre.xml EX-101.PRE 13130
21 EXTRACTED XBRL INSTANCE DOCUMENT angn-20240523_htm.xml XML 2816
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 24979950
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)